The QualityStocks Daily Monday, June 18th, 2018

Today's Top 3 Investment Newsletters

MarketBeat (TPAC) +900.00%

Small Cap Firm (GEVO) +261.82%

MarketBeat (SCIE) +100.00%

The QualityStocks Daily Stock List

DSG Global, Inc. (DSGT)

Epic Stock Picks, StockHideout, Stock Preacher, Penny Stocks Finder, SuperStockTips, Penny Stock Craze, SMS Penny Picks, eliteotc, WININGOTC, Wall Street Beauties, StockRockandRoll, The Observer, OTC Markets, PennyStockLocks, ResearchOTC, InvestorSoup, and Beacon Equity Research reported previously on DSG Global, Inc. (DSGT), and we report on the Company today, here at the QualityStocks Daily Newsletter.

DSG Global, Inc. is a technology development company whose shares trade on the OTCQB. The Company engages in the design, manufacture, and marketing of fleet management solutions for the golf industry, and also commercial, government, and military applications worldwide. DSG Global has historically concentrated on the golf industry. It has grown to become a leader in the Fleet Management category in the golf industry. DSG Global is based in Surrey, British Columbia.

The Company provides patented electronic tracking systems and fleet management solutions to golf courses. These allow for remote management of the course's fleet of golf carts, turf equipment, as well as utility vehicles. DSG is best known for its advanced GPS TAG System for golf cart and turf equipment fleet management.

DSG Global’s technology is installed in more than 10,000 vehicles on golf courses globally. The Company has an installed base of daily-fee and resort golf courses. Its cart-mounted Touch® display screens seamlessly deliver banner advertisements and full-motion videos while on the golf course.

Fundamentally, golf course operators manage their fleet of golf carts, turf equipment, and utility vehicles remotely, using DSG Global’s SaaS (Software as a Service) technology and advanced GPS hardware. DSG has acquired Impact Tournament Solutions, along with Impact’s team of experts, to run the Tournament Solutions Division of DSG Global.

DSG Global is currently branching into several new streams of revenue via programmatic advertising, licensing, and distribution. Additionally, the Company is expanding into Commercial Fleet Management and Agricultural applications. It realized record European sales in 2017 because of new installation contracts with top rated European Golf Management businesses. Furthermore, DSG Global is expanding into Raptor Single Rider Golf Car and 100E Fully Loaded Mullen Golf Cars, 2 and 4 seaters and Agricultural applications.

DSG Global has officially partnered with golf course video flyover company, STEADY MOTION. This is to bring the best interactive flyover videos to the golf sports industry. These flyover videos include professional, broadcast television quality audio narration, advanced color correction, and interactive course tours ready to be displayed on the DSG TOUCH screens and on golf course web portals.

Last month, DSG Global announced that it is introducing to the global market the first ever Infinity 12" High Definition display. This display is equipped with streaming music, video, Bluetooth, stock market and sports scores, and the top-graded flyovers in the nation, credit card tap availability, dual speakers and Programmatic Advertising.

Furthermore, last month, DSG Global announced that it has taken first steps to move towards exploring potential use cases, which it has identified for blockchain and its related technologies to be applied to the golf industry.

Mr. Robert Silzer, DSG Global’s Chief Executive Officer, stated, "Blockchain will definitely change the golf industry and DSG plans to play a leading role to bring this change to fruition. I believe this technology will revitalize the golf industry. It can build a new bridge between golf and the millennials and raise new enthusiasm for the sport. It can release tremendous value that is currently untapped."

DSG Global, Inc. (DSGT), closed Monday's trading session at $0.0016, up 6.67%, on 77,099,618 volume with 140 trades. The average volume for the last 60 days is 35,886,249 and the stock's 52-week low/high is $0.001/$0.095.


BioCorRx, Inc. (BICX)

Equity Observer, SmallCapVoice, Value Penny Stocks, MassiveStockProfits, BUYINS.NET, OTPicks, Damn Good Penny Picks, Penny Stock Newsletter, PREPUMP STOCKS, Penny Picks, and PennyStocks24 reported earlier on BioCorRx, Inc. (BICX), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, BioCorRx, Inc. is a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions. It provides a unique approach to the treatment of substance abuse addiction and has its BioCorRx® Recovery Program. The BioCorRx® Recovery Program is a non-addictive, medication-assisted treatment (MAT) program. BioCorRx’s concentration is on improving the quality of life for recovering addicts. BioCorRx is based in Anaheim, California.

The BioCorRx® Recovery Program comprises two main components. The first component consists of an outpatient implant procedure performed by a licensed physician. The implant delivers the non-addictive medicine, naltrexone, an opioid antagonist, which can substantially decrease physical cravings for alcohol and opioids.

The second component is a one-on-one proprietary counseling program. It is particularly tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatments.

In addition, the Company has expanded the support structure to include 12 months of a peer-support system using trained recovery specialists. Moreover, BioCorRx is developing a patent pending injectable form of naltrexone.

BioCorRx also has a research and development (R&D) subsidiary, BioCorRx Pharmaceuticals. Currently, this subsidiary is developing a new injectable naltrexone technology (BICX101) via a partnership with TheraKine Ltd.

BioCorRx’s plan is to seek Food and Drug Administration (FDA) approval for BICX101 and/or its naltrexone implant product(s). BICX101 is a sustained release, injectable naltrexone for the treatment of opioid abuse and alcoholism.

Last month, BioCorRx announced a pilot for the BioCorRx® Recovery Program in collaboration with the One Day at a Time Program (ODAAT). This is a program funded by the City of Philadelphia and State of Pennsylvania.

This will be a paid demonstration pilot in which the BioCorRx Recovery Program will be utilized to treat a number of individuals suffering from opioid and alcohol use disorders. The ODAAT program assists greater than 56,000 residents of Philadelphia.

Earlier this month, BioCorRx announced that following the pre-Investigational New Drug (pre-IND) meeting with the U.S. Food and Drug Administration (FDA), and based on the FDA’s responses to BioCorRx’s development plan for BICX102, it has extended Dr. Balbir S. Brar’s agreement as VP of Drug Development for the BioCorRx Pharmaceuticals subsidiary for an additional one year period.

Dr. Brar has more than 25 years of experience in drug and device development. This includes international regulatory submissions for greater than 50 INDs, 510(k)s and 505(b)(2)s, and also approval of 8 NDAs for drugs now in the marketplace.

Last week, BioCorRx announced the results of its pre-IND meeting with the FDA. The FDA judged the 505(b)(2) pathway as an acceptable route for approval for BICX102. The 505(b)(2) pathway is intended to provide an abbreviated route to approval with less study requirements than traditional applications. BICX102 is a sustained release naltrexone implant for the treatment of opioid and alcohol use disorders.

BioCorRx, Inc. (BICX), closed Monday's trading session at $0.1385, up 2.59%, on 294,070 volume with 34 trades. The average volume for the last 60 days is 250,604 and the stock's 52-week low/high is $0.0426/$0.282.


Envision Solar International, Inc. (EVSI)

SmarTrend Newsletters, OTCJournal, Greenbackers, RedChip, FeedBlitz, Hotstocked, Stock News Now, SmallCapVoice, and Stockwire reported on Envision Solar International, Inc. (EVSI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Envision Solar International, Inc. is the leading renewably energized EV charging, outdoor media and energy security products company. It is a developer of solar products and proprietary technology solutions. The Company designs, manufactures, and deploys unique, renewably energized, EV charging and media and branding systems. Envision Solar International is OTCQB-listed and is based in San Diego, California.

The Company’s products include the patented EV ARC™ and Solar Tree® product lines. All of Envision Solar’s products can be enhanced with EnvisionTrak™ patented solar tracking, ARC Technology™ energy storage, SunCharge™ Electric Vehicle Charging Stations, and digital advertising packages.

Envision Solar has designed and incorporated EnvisionTrak, its proprietary and patented tracking solution, to the Solar Tree structure. The Company has deployed its latest generation of Solar Tree products, the Solar Tree HVLC (High Value, Low Cost) collection.

The new Solar Tree product incorporates its latest engineering and fabrication improvements. Its Solar Tree® structure works as a billboard for a company’s green credentials. This is while producing clean energy and improving the aesthetics of any parking lot.

In addition, Envision Solar has developed the abovementioned EV ARC™. The Company has observed that the EV ARC™ (Electric Vehicle Autonomous Renewable Charger) can solve numerous problems associated with electric vehicle charging infrastructure deployments.

The EV ARC™ fits inside a parking space. It produces enough clean, solar electricity to power up to 225 miles of EV driving in a day.

At the beginning of February, Envision Solar International announced that its new EV-Standard™ product is currently patent pending and in advanced-stage product development preparing for commercialization in Q2 2018.

Envision Solar International Chief Executive Officer, Mr Desmond Wheatley, said, "Our new EV-Standard combines everything we have learned in a mass-market, curbside solution. Many Americans cannot charge their EVs at home and cities need a meaningful and economically viable curbside charging solution. EV-Standard is it. The big city customers I've shared this with view it as a potential game changer."

The EV-Standard is a fully integrated lamp standard and EV charging product. It combines renewable energy, a grid connection, and energy storage to provide a meaningful, on-street, Level II EV charging experience for the millions of Americans who cannot charge at home or at work.

Recently, Envision Solar International announced unaudited Revenue results for January 2018. In January, the Company attained monthly Revenue of $2 million. This represents the highest monthly revenue in Envision’s history. Revenue was realized via the delivery of its EV ARC™ products to government customers.

Envision Solar International, Inc. (EVSI), closed Monday's trading session at $0.27, up 8.00%, on 45,950 volume with 17 trades. The average volume for the last 60 days is 95,414 and the stock's 52-week low/high is $0.09/$0.429.


OptimizeRx Corp. (OPRX)

Streetwise Reports, InvestorsHub, GuruFocus, Marketbeat, MarketWatch, Barchart, Stockhouse, 4-Traders, NetworkNewsWire, and Bull in Advantage reported on OptimizeRx Corp. (OPRX), and we also report on the Company, here at the QualityStocks Daily Newsletter.

OptimizeRx Corp. is the nation’s top provider of digital health messaging for the pharmaceutical industry. The Company is the leading aggregator of pharmaceutical-sponsored services in electronic health record (EHR) platforms. A health technology software enterprise, OptimizeRx is headquartered in Rochester, Michigan.

The Company’s core product is a novel patient financial support software application. It replaces traditional physical drug samples through automating the process of distributing coupons and vouchers into healthcare providers’ eRx workflow, then automatically delivering them electronically to the pharmacy. It promotes patients’ savings and support from the world's largest pharmaceutical companies.

The application replaces drug samples with electronic trial vouchers and co-pay coupon savings. These are electronically added to an e-Prescription and sent electronically to the pharmacy and are integrated within top Electronic Health Record (EHR) platforms in the nation.

Additionally, OptimizeRx launched its OPTIMZEHR™. This is its consulting and implementation practice to assist pharmaceutical-biotechnology companies and healthcare provider platforms in determining and executing on mutually beneficial opportunities to jointly assist physicians and patients within their EHR workflow.

OptimizeRx has a group of services, which integrate total brand support into the EHR. This leads to enhanced patient care and improved outcomes. These offerings include Brand Messaging and Brand Support. The Company’s core product has been financial messaging, providing physicians with electronic coupons, co-pay offers, and vouchers for their patients at the point of care (PoC).

In February of this year, OptimizeRx announced that it gained access to the electronic health record (EHR) system of NextGen Healthcare. OptimizeRx services will operate within the NextGen Healthcare EHR workflow and notify healthcare providers (HCPs) in real-time of potential prescription savings and support information for their patients. NextGen is a top five EHR and a unit of Quality Systems.

OptimizeRx has partnered with EvidenceCare, a Nashville-based provider of a cloud-based clinical decision support (CDS) tool for individual clinicians, hospitals and clinics. EvidenceCare’s network comprises greater than 5,000 users, including hospitals that layer the EvidenceCare CDS tool onto electronic health records (EHRs).

The partnership permits EvidenceCare to deliver OptimizeRx’s digital health messaging to healthcare providers at the point-of-care. This includes financial, clinical, as well as brand messaging for pharmaceutical companies.

In addition, OptimizeRx has partnered with Patient Connect to deliver real-time messaging at point-of-care across Europe. Patient Connect is a worldwide provider of patient support and engagement through digital. Patient Connect has reach to about 450 million patients via its international pharmacy network partners, which provide coverage of 50 percent or more of all dispensed retail scripts in important markets.

Last week, OptimizeRx announced that it has been invited to participate at the ROTH London Conference taking place June 19-20, 2018 at the Dorchester Hotel in London, U.K. OptimizeRx Chief Executive Officer, Mr. William Febbo, is scheduled to participate in one-on-one meetings. The event is for institutional clients of ROTH and is by invitation only.

OptimizeRx Corp. (OPRX), closed Monday's trading session at $8.95, up 11.87%, on 188,650 volume with 91 trades. The average volume for the last 60 days is 1,656 and the stock's 52-week low/high is $2.49/$9.00.


Lightwave Logic, Inc. (LWLG)

FeedBlitz, SmallCapVoice, PennyStocks24, SmallCap Fortunes, StockGuru, OTC Picks, Standout Stocks, and HotOTC reported previously on Lightwave Logic, Inc. (LWLG), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Lightwave Logic is a technology business concentrating on the development of Next Generation Photonic Devices and Non Linear Optical Polymer Materials Systems for applications in high-speed fiber-optic data communications and telecommunications. The Company creates prototype electro-optic demonstration devices. Lightwave Logic is based in Longmont, Colorado and the Company lists on the OTC Markets.

Lightwave Logic is moving toward commercialization of next generation photonic devices utilizing its high-activity and high-stability organic polymers for applications in data communications and telecommunications markets. The Company is using organic nonlinear electro-optical and all-optical polymers (plastic) as the foundation for a series of proprietary (internal and licensed to external partners) advanced Integrated Optical Devices that have wide-ranging application in telecommunications, data communications, and optical computing for use in commercial and military markets.

Lightwave Logic has integrated its proprietary Perkinamine™ chromophore technology with other chromophores based in part on elements of proprietary, in-licensed technologies. This has resulted in a strong and durable nonlinear organic electro-optical (EO) material, which will be used in photonic device development. It is founded on the Company’s multi-chromophore approach that enables two or more chromophores to work together.

The Company’s Polymer Photonics Integrated Circuit (P2ICTM) is analogous to an electronic integrated circuit. However, it incorporates two or more optical functions or devices integrated onto a single substrate platform. Lightwave Logic’s expectation is that P2ICsTM will become a vital engine in the transceiver market over the next decade.

Lightwave Logic announced in September of 2017 that it achieved outstanding performance of its ridge waveguide Mach-Zehnder modulators ahead of schedule, with bandwidth performance levels that will enable 50Gbps modulation in fiber-optic communications. This important achievement will allow users to use arrays of 4 x 50Gbps polymer modulators using PAM-4 encoding to access 400Gbps data rate systems.

Lightwave Logic’s Intellectual Property (IP) has expanded considerably over the last year. The Company is developing its P2IC into prototypes. It filed more than 6 patents during 2017. It is readying several other inventions for formal filing--most likely early this year.

The Company expects to continue innovating with its P2IC platform this year. It also expects to at least maintain this level of invention during the whole of 2018. In total, Lightwave Logic’s patent portfolio comprises 13 granted patents. These include 4 from the United States, 1 from Canada, 5 from the European Union (EU), 2 from Japan, and 1 from China.

Lightwave Logic, Inc. (LWLG), closed Monday's trading session at $1.20, up 4.35%, on 185,744 volume with 135 trades. The average volume for the last 60 days is 60,570 and the stock's 52-week low/high is $0.9851/$1.64.


Star Navigation Systems Group Ltd. (SNAVF)

The Stock Market Watch, Speculating Stocks, Jet Life Penny Stocks, High Rising Stocks, StreetInsider, Investing News Alerts, MarketWatch, Stockhouse, Marketwired, OTC Markets, Business Insider, Equities, and PennyStockHub reported on Star Navigation Systems Group Ltd. (SNAVF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Star Navigation Systems Group Ltd. owns the exclusive worldwide license to its proprietary, patented In-flight Safety Monitoring System, STAR-ISMS®. This is the heart of the STAR-A.D.S. ® System. The Company’s M.M.I. Division designs and manufactures high performance, mission critical, flight deck flat panel displays for defense and commercial aviation industries globally.

Star Navigation Systems is headquartered in Toronto, Ontario. The Company’s shares trade on OTC Markets Group’s OTCQB. Star serves commercial airlines, helicopters, and OEMs (original equipment manufacturers), and also the military aviation search and rescue industries.

The Company provides hardware and software platforms. This includes the STAR-A.D.S. ™, which is real-time global tracking and monitoring systems. Additionally, platforms include the STAR-MMI™, which is flat panel and LCD displays and control units.

STAR-MMI™ has developed a broad range of AMLCD flat panel display sizes, with LED Backlights, resolutions, and orientations. These displays are found on aircraft and simulators, from P-3 Orion and C-130 aircraft, to Sikorsky and AgustaWestland helicopters, among others.

Star Navigation Systems developed the STAR-ISMS® In-flight Safety Monitoring System. This is the first system in the world to feature in-flight data monitoring and diagnostics with a real-time, secure connection between aircraft and ground.

STAR-ISMS® continuously monitors selected avionics systems on the aircraft from power-on to power-off. It instantly analyzes the data, and transmits selected data and any incident alerts, via satellite to the operator.

In addition, the Company offers STAR-ISMS-Medevac. This is a real-time telemedicine for emergency medical evacuation by way of air transportation. Furthermore, Star Navigation Systems offers STAT-T.T.T. This is a satellite flight tracking and voice/text communications system.

Star Navigation Systems Group announced this past January its first orders of 2018 for its’ STAR Man Machine Interface Division (STAR- M.M.I. ™). STAR- M.M.I. ™ received a new set of repair orders from Lockheed Martin under the earlier implemented agreement for refurbishment and maintenance. The agreement covers activities up to the year 2021.

Earlier this month, Star Navigation Systems Group announced that its R&D Department completed development of its In-Flight System Aided Medical Monitoring system (STAR-ISAMM™). Using the Company’s patented STAR-A.D.S. ® System, which is an on-board, real-time flight data monitoring and tracking system, STAR-ISAMM™ directly addresses the necessity to improve the in-flight transmission to a hospital of medical data regarding an on-board emergency patient. The System interfaces with existing bio-medical equipment aboard the MEDEVAC helicopter.

Last week, Star Navigation Systems confirmed GADSS compatibility. The Company, having participated in the International Civil Aviation Organization’s (ICAO) Working Groups, was pleased to see that ICAO’s Global Aeronautical Distress and Safety System (GADSS) Advisory Group updated their Concept of Operations and Standard and Recommended Practices late in 2017.

ICAO’s Concept of Operations recommends that beginning in November 2018, there should be autonomous aircraft flight tracking every 15 minutes over oceanic areas. Moreover, as of January 2021, ICAO’s Concept of Operations recommends that there should be autonomous location and tracking of aircraft in distress at least once every minute. Star Navigation Systems’ STAR-A.D.S. ® System already surpasses compliance with all of the ICAO GADSS recommendations and developments planned from 2018 to 2021 and beyond.

Star Navigation Systems Group Ltd. (SNAVF), closed Monday's trading session at $0.0335, even for the day. The average volume for the last 60 days is 12,755 and the stock's 52-week low/high is $0.0335/$0.185.


Fiore Gold Ltd. (FIOGF)

Investors Hangout, Energy and Gold, Stock Orange, Barchart, Stockhouse, Stockwatch, and WatchDog Stocks reported on Fiore Gold Ltd. (FIOGF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Fiore Gold Ltd. is a new America’s-focused gold producer and explorer. It has the producing Pan Mine in the State of Nevada. In addition, the Company has a group of exploration projects in Nevada, Washington and Chile. Fiore Gold has offices in Toronto, Ontario; Vancouver, British Columbia; and Englewood, Colorado.

The Company’s aim is to build a new mid-tier mining company in the world’s top mining jurisdictions. Its initial goal is on becoming a 150,000-ounce/year gold producer.

Concerning North American Projects, Fiore Gold’s assets include the aforementioned, producing Pan Mine near Eureka, Nevada. Furthermore, assets include the nearby Gold Rock exploration project. The Company additionally controls the Golden Eagle advanced exploration project in Washington State.

The Pan Mine is a Carlin-style, sediment-hosted, gold-only deposit. It consists of three main zones of mineralization that has currently been traced for more than 6,000 feet along the north-south Branham Fault. The 2017 Pan Mine Feasibility Study (FS) defines Proven and Probable reserves of 318,000 gold ounces at an average grade of 0.51 g/t gold (0.015 oz/ton).

Regarding South American Properties, the Company has its Pampas El Peñon properties; the Cerro Tostado project; and the Rio Loa property. The Pampas El Peñon property consists of 13 mining claims totaling 3,400 hectares. It is positioned roughly 130 kilometers southeast of Antofagasta, Chile.

The Cerro Tostado (South America) project comprises five concessions totaling approximately 1,500 ha situated in Region II about 125 km southeast of Antofagasta. Cerro Tostado is just south of the main and Fortuna zones of Yamana Gold's flagship El Peñon Mine.

The Rio Loa property is in the northern part of the prolific Maricunga gold belt. The 1,000 Ha Rio Loa property is around 25 km south of Salares Norte.

Fiore Gold earlier announced the commencement of exploration drilling at its Pan Mine in Nevada, as part of a longer-term program intended to expand the resource and reserve base at Pan. This current program will comprise around 11,500 feet of reverse circulation drilling and be centered in the vicinity of the North Pit that hosts most of the silica-rich rocky ore at Pan. Drilling will also take place in the Central area of the deposit to expand existing resources there and test new targets.

In May, Fiore Gold provided results from an additional seven holes of its 2018 drill program at its Pan Mine in Nevada. Highlights from these seven holes include Hole PND18-27 returning 16.8 meters of 0.96 g/t (55 ft of 0.028 oz/t) at Red Hill.

Hole PND18-28 intercepted 45.7 m of 0.72 g/t gold (150 ft of 0.021 oz/t gold) at Red Hill. Hole PND18-29 drilled 36.6 m of 0.56 g/t gold (120 ft of 0.016 oz/t) in the West Contact area.

For Q2 2018, Fiore Gold had gold production of 8,695 ounces and a 31 percent increase over Q1 2018. The Company had gold sales of 8,673 ounces at an average realized price of $1,327 per ounce.

It had Q2 2018 all-in sustaining costs (AISC) per ounce sold of $989. This represents a 45 percent decrease from Q1 2018. Fiore maintained an increased mining rate at the Pan Mine above 14,000 ore tons per day (tpd).

Fiore Gold Ltd. (FIOGF), closed Monday's trading session at $0.414, down 0.24%, on 51,704 volume with 25 trades. The average volume for the last 60 days is 54,635 and the stock's 52-week low/high is $0.38/$0.9537.


Alternative Investment Corporation (AIKO)

OTC Markets, InvestorsHub, MarketWatch, Stockhouse, Equity Base, 4-Traders, Market Exclusive, Simply Wall St, GuruFocus, Wealth Simple, Wallet Investor, Investopedia, TradingView, Stockopedia, Barchart, Stockscores, and Stockwolf reported on Alternative Investment Corporation (AIKO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Alternative Investment Corporation (AICO) is a real estate development and acquisition organization. The Company’s focus is on properties in the United States and Japan. AICO has developed a signature approach to managing all facets of the development process. This is from property acquisition, financing and design to construction and marketing.

Established in 2007, the Company previously went by the name Paradigm Resource Management Corporation. It changed its name to Alternative Investment Corporation in September of 2015. AICO’s shares trade on the OTC Markets Group’s OTCQB. The Company has its corporate headquarters in New York, New York.

AICO is a full service developer. It has the ability to quickly move any project from site selection, acquisition and financing to construction, leasing, property management and maintenance. AICO chiefly concentrates on distressed real estate assets and/or alternative real estate developments.

The Company’s emphasis is Technological Innovation, Sustainable Design, as well as Adaptive Reuse for contemporary market requirements. Its dedication is to build close relationships with strategic partners, tenants and investors.

The Company’s other businesses include Green Buildings and Technology. Regarding Technology, AICO has invested in technology start-ups, which can be implemented into its development projects.

AICO’s Projects include AICO Plaza. This is in Takarazuka, Japan. AICO Plaza is 5,162.73 square meters. It has 6 residential floors, 4 commercial floors and adjacent parking with 219 parking spaces.

Another of the Company’s projects is Kyoto Plaza. This plaza is in the thousand year capital, Kyoto, the capital city of Kyoto Prefecture in Honshu, Japan. This project is 7280.49373 square feet. The property is 11 floors. This includes a basement level.

Kyoto Plaza is a combination of commercial and residential space. The Plaza offers 4 floors of stores and parking, 5 residential floors, a data center and storage.

AICO also has its Basil and Barns Project. Basil and Barns is on 101 acres of land in Sullivan County. It is two hours north of New York City.

Basil & Barns offers farmhouse villas in an innovative combination of rustic meets upscale resort. Basil & Barns has 30 farmhouse villas. Each of these is 1725 square feet - 2 bed/2 bath. They can convert into 1 bedrooms and studios.

Alternative Investment Corporation (AIKO), closed Monday's trading session at $1.25, down 16.67%, on 11,646 volume with 20 trades. The average volume for the last 60 days is 496 and the stock's 52-week low/high is $0.65/$29.40.


IDM Mining Ltd. (IDMMF)

InvestorsHub, Stockhouse, and MarketWatch reported on IDM Mining Ltd. (IDMMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

IDM Mining Ltd. is a mineral exploration and development company based in Vancouver, British Columbia. It concentrates on low capital expenditure, high-grade precious metal asset development. The Company’s current exploration and development activities center on precious metals in British Columbia (B.C.). IDM’s chief focus is on the high-grade, underground Red Mountain Gold Project. IDM Mining lists on the OTC Markets’ OTCQB.

The Red Mountain Gold Project is 15 kilometers east of Stewart, B.C. It comprises 17,125 hectares. IDM Mining is advancing through the B.C. and Canadian environmental assessment processes with complete, thorough, and continuing consultation with Nisga'a Nation.

Red Mountain has first-rate exploration potential for additional discoveries along a 12-kilometer trend of manifold prospects and favorable geology. The Company is advancing a Feasibility Study (FS) for a high-grade, underground gold mine. It envisions mainly bulk underground mining methods and the production of gold doré on site.

Red Mountain hosts a well-drilled, high-grade resource, accessed by a production-sized underground decline. The deposit (at an average potential mining width of 16 meters) is amenable to low-cost bulk mining techniques such as longhole stoping.

IDM Mining announced in February 2018 significant and encouraging progress from the geologic compilation of drill results from the 2017 exploration program at the Red Mountain Gold Project.

In May, IDM Mining provided a status update for the Red Mountain Underground Gold Project that is within the B.C. Provincial Environmental Assessment (EA) and Federal Environmental Impact Statement (EIS) Review Process.

Mr. Robert McLeod, IDM Mining President and Chief Executive Officer, said in May, "We are pleased that the 2018 resource estimate is nearing completion and to be included in an update to the 2017 Feasibility Study. Additional updates to the feasibility study will include an optimized underground mine plan and capital and operating efficiencies identified during the value engineering phase. We also look forward to finalizing the EA and EIS review process and the Benefits Agreement with the Nisga'a Nation."

Earlier this month, IDM Mining announced that it and Sunvest Minerals signed a Letter of Intent (LOI) where IDM would provide Sunvest with technical and geological consultation work and also logistical and community guidance for its Clone Gold Property. This Property is south of IDM Mining’s Red Mountain Property. Both properties are east of Stewart, in B.C.'s Golden Triangle.

IDM Mining Ltd. (IDMMF), closed Monday's trading session at $0.059, up 1.55%, on 17,000 volume with 5 trades. The average volume for the last 60 days is 65,846 and the stock's 52-week low/high is $0.0449/$0.1247.


Maricann Group, Inc. (MRRCF)

Stockhouse, The Street, MarketWatch, 4-Traders,, Marketwired, Investors Hub, Investopedia, OTC Markets, Barchart, Weed Newswire, Insider Financial, YCharts, and TradingView reported on Maricann Group, Inc. (MRRCF), and we are highlighting the Company as well, here at the QualityStocks Daily Newsletter.

Listed on the OTCQB, Maricann Group, Inc. produces and distributes marijuana for medical purposes. It offers dried marijuana, cannabis oil, and gums. In addition, the Company provides accessories. This includes vaporizers, grinders, as well as other paraphernalia. Maricann Group has its head office in Langton, Ontario.

Maricann Group is a licensed producer of medical cannabis under Canada’s Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company secured a cultivation license in March 2014. It started selling dried cannabis in January 2015 and extracts in October 2016. Maricann Group has federal licenses in Canada to cultivate, extract, formulate, and also distribute cannabis.

Maricann’s Germany-based Ebersbach facility targets the huge European market with 820,000 sq. ft. of cultivation space and more than 12,000 patients. Maricann Group has developed educational programming for patients and healthcare professionals. Via exclusive pharmacy agreements with approximately 20 percent of the nation’s pharmacies, Maricann is working to become a foremost provider of cannabis at physical point-of-sale locations that patients trust.

The Company’s new, state-of-the-art, fully dedicated cannabis production facility in Langton is on 100 acres of land. Phase One is to be completed in Q2 2018. This will give Maricann capacity to grow 22,500 kg.

Phase 2 construction will start in the second half of 2018. It will provide an additional 635,000 square feet of grow space. Phase 3 is also scheduled to start in the second half of this year. It will bring the Company’s total growing and processing space to 942,000 square feet.

Maricann Group acquired NanoLeaf Technologies in August 2017. NanoLeaf is a biotechnology company possessing licensing rights to several internationally patented technologies, which provide proven pharmaceutical, nutraceutical, cosmetic, and functional beverage drug delivery formulations. Maricann’s Vesisorb is the first standardized dose cannabinoid soft gel capsule with a nano-dispersed carrier for the drug that is ideal for ingestional bioavailability.

In November 2017, Maricann Group announced that it entered into a non-binding Letter of Intent (LOI) with the Alliance of Beverage Licensees (ABLE BC), the advocacy organization representing British Columbia's private liquor industry that outlines a proposed relationship between ABLE BC and Maricann Group for, among other things, the supply of Maricann product to ABLE BC members.

With this LOI, ABLE BC will agree to provide Maricann with distribution channels for its recreational stable of products. This includes JuJu Royal's curated quality strains. This will ensure ABLE's over 1,000 members comprising private liquor stores, neighborhood pubs, bars/nightclubs and hotel liquor licensees have access to Maricann's stable of established premium cannabis products.

Maricann Group, Inc. (MRRCF), closed Monday's trading session at $1.3832, up 3.22%, on 28,118 volume with 59 trades. The average volume for the last 60 days is 68,439 and the stock's 52-week low/high is $0.8698/$3.60.


Nu-Med Plus, Inc. (NUMD)

Stockhouse, OTC Markets, Marketwired, Investing News, Street Insider, The Street, The StreetWise Reports, MarketWatch, Stockopedia, Business Insider, Morningstar, GuruFocus, CapitalCube, Last10k, TradingView, Wallmine, Stockwatch, Wallet Investor, and VentureLine reported on Nu-Med Plus, Inc. (NUMD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

A medical device company, Nu-Med Plus, Inc. investigates and develops applications of Nitric Oxide technologies in the medical field. The Company formed to explore medical applications of newly developed technologies. Its business strategy is to concentrate on high growth potential markets where there is a clearly defined need recognized by the medical community, which can be addressed by Nu-Med Plus and its technical expertise. OTCQB-listed, the Company is based in Salt Lake City, Utah.

Inhaled Nitric Oxide (INO) is a medically essential gas. It is currently used in Neonate Hypoxia therapy (inadequate oxygen level in newborns), COPD and other pulmonary problems. INO may have future applications for an array of other diseases and medical complications that are presently being investigated. Nu-Med has the capability to deliver high purity Inhaled Nitric Oxide (INO) to the patient at point of use.

Nu-Med Plus’ markets include neonatal complications, COPD, Tuberculosis, Malaria, and ARDS (a severe lung syndrome with no known cure). The Company’s team has developed a new Nitric Oxide (NO) gas delivery system. This system provides a continuous intra-breath concentration of therapeutic NO to medically supervised patients who are on ventilators in a hospital setting.

Earlier this month, Nu-Med Plus announced its patent filing for its ground-breaking chemically reactive coating. The coating ensures that only a contaminant free nitric oxide, a life saving drug for neonates, reaches the patient.

The Company has developed a unique method for a reactive coating, which chemically bonds or adheres to the inside surface of common medical gas delivery tubing. In essence, the coating removes toxic contaminants that are found in nitric oxide delivery systems.

Last week, Nu-Med Plus announced it chose Millennium Biosciences as its strategic partner for company quality and regulatory service.  Mr. Mike D’Amico leads Millennium. Mr. D’Amico has been a successful, focused, quality-driven scientific leader with international strategic Quality systems and Regulatory experience within the scientific community.

Nu-Med Plus, Inc. (NUMD), closed Monday's trading session at $1.00, up 5.26%, on 300 volume with 1 trade. The average volume for the last 60 days is 1,505 and the stock's 52-week low/high is $0.16/$1.01.


Weyland Tech, Inc. (WEYL)

DreamTeamNetwork, Wall Street Mover, OTC Journal, Stockhouse, Simply Wall St, and InvestorsHub reported previously on Weyland Tech, Inc. (WEYL), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Weyland Tech, Inc. is a provider of mobile business applications. The focus of the Company’s CreateApp platform is on the Asia markets. Weyland Tech currently offers the CreateApp platform directly in Singapore, India (Jaipur), and the United States and Canada. OTCQX-listed, Weyland Tech is headquartered in Hong Kong.

The "CreateApp" platform enables SMBs (Small-Medium-Sized Businesses) to create a mobile application without the requirement of technical knowledge and background. The Company’s CreateApp platform is provided in 14 languages.

Weyland Tech currently offers a DIY (Do-it-Yourself) App builder via a 'white label' platform. It offers this through strategic partnerships in the EU (minus Russia, Turkey, Armenia, Azerbaijan); Malaysia; Hong Kong/South China; Indonesia; and North/Central/South America. It will offer this in Korea by way of IAM, Inc.

Last month, Weyland Tech provided an update on its recently announced spinoff of its eWallet business. Company Management is now finalizing an engagement letter with a ‘Big 5’ consulting firm to advise it on the spinoff and IPO (Initial Public Offering) structure and also continuing audit functions for the eWallet business. The eWallet business operated in a ‘closed Beta’ environment from December 2017 to April 2018. It was on an annual run-rate of US$5.0 million Gross Transaction Volume (GTV) with 15 sales people on staff and zero marketing and advertising expenditure.

Recent hires have augmented the present sales staff to 24. The Company’s plan is to have 400 sales staff in place by the end of this year with a targeted GTV of US$25-35 million run-rate. The 2019 objective is to have 1,000 sales staff and a target GTV of greater than US$80 million.

Additionally, on May 23, 2018, Weyland Tech released remarks by its Chief Executive Officer, Mr. Brent Suen, on the Company’s AtozPay e-wallet. Mr. Suen said, “The Company’s management is pleased to announce that AtozPay is officially out of beta. We are also excited to announce that AtozPay’s gross transaction value (GTV) has grown to $6.2 Million up from the $5.0 Million announced just two weeks ago, and that the rate of GTV growth increased by more than 100 percent since the exit from beta. We are well on our way to the $25-35 million in GTV targeted by year end….”

Weyland Tech, Inc. (WEYL), closed Monday's trading session at $1.67, up 5.03%, on 8,791 volume with 18 trades. The average volume for the last 60 days is 29,417 and the stock's 52-week low/high is $1.31/$7.08.


The QualityStocks Company Corner

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

SinglePoint Inc. (OTCQB:SING) is pleased to announce the successful completion and filing of the company’s Form 10 Registration Statement with the Securities and Exchange Commission. This is an important step in helping the company establish credibility in the investment community. Also today, the company was highlighted in an article detailing Blockchain’s strong year, with The Wall Street Journal having released its annual list of “Tech Companies to Watch,” where in 5 of the 25 companies listed were blockchain-related.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed the day's trading session at $0.0565, up 10.14%, on 12,823,997 volume with 640 trades. The average volume for the last 60 days is 10,431,370 and the stock's 52-week low/high is $0.0132/$0.415.

Recent News



The QualityStocks Daily Newsletter would like to spotlight EVIO, Inc. (EVIO).

EVIO Inc. (OTCQB: EVIO) ("EVIO" or "the Company"), a leading provider of cannabis testing and scientific research for the regulated cannabis industry, today announced that EVIO Canada will be exhibiting alongside Keystone Labs Inc. at the International Cannabis Business Conference (ICBC) in Vancouver from June 24 – 25.

EVIO, Inc. (EVIO), via the EVIO Labs division, is the nation’s leading provider of accredited analytical testing, scientific research and advisory services to the regulated cannabis industry. EVIO Labs provides state-mandated ancillary services that are required to ensure the safety and quality of the nation’s cannabis supply. EVIO Labs has performed over 50,000 tests during the past two years and grown from one laboratory in Oregon to nine labs spanning California, Oregon, Colorado, Massachusetts and Florida.

EVIO Labs is driving the cannabis testing industry by providing clients nationwide with consistent high-quality cannabis analytical services backed by quality control assurances. The company also provides advisory services that help cannabis producers and retailers enhance production processes, achieve regulatory compliance and meet quality goals.

EVIO Labs is on track to open 18 laboratories by the end of 2018 at locations around the United States. The Oregon-based company provides analytical services that include testing cannabis and industrial hemp flower, extracts and infused products. The labs specialize in performing the following tests:

  • Cannabinoid analysis, which properly characterizes the many primary cannabinoids found in cannabis including THC, CBD, and several other cannabinoids.
  • Terpene analysis, which identifies the aromatic compounds of the plant (terpene), which can help identify the therapeutic potential of a cannabis flower or extract.
  • Moisture content and water activity, which measure the moisture levels of dried cannabis and are indicators of microbiological growth potential.
  • Pesticide residue analysis of over 100 different pesticides, herbicides, fungicides, growth regulators and other agrochemicals that may be present on cannabis.
  • Detection of harmful residual solvents left behind in the cannabis extract production process.
  • Microbial testing screen for bacterial and fungal contamination in cannabis and cannabis-infused products.
  • Detection of heavy metals including lead, cadmium, mercury, and arsenic.

EVIO Labs is rapidly becoming the nation’s leading cannabis biotechnology company. Led by a management team with extensive experience in designing and rolling out successful business ventures, product research and development, regulatory and compliance protocols, medical cannabis cultivation, production and analytical chemistry techniques, EVIO Labs is prepared to take advantage of today’s fastest growing industry.

EVIO, Inc. (EVIO), closed the day's trading session at $1.17, up 6.36%, on 66,825 volume with 41 trades. The average volume for the last 60 days is 83,676 and the stock's 52-week low/high is $0.47/$2.70.

Recent News


Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB:PBIO) (“PBI” and “the Company”) was recently interviewed on Uptick Newswire’s “Stock Day” podcast. Schumacher discussed the Company’s continued financial success, the significant amount of debt the Company has converted into equity over the past 30 days, and the Company’s plans to up-list to a national exchange before the year is out.

Pressure BioSciences Inc. (OTCQB: PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed the day's trading session at $4.10, up 5.13%, on 5,775 volume with 15 trades. The average volume for the last 60 days is 1,300 and the stock's 52-week low/high is $0.70/$8.50.

Recent News


The Green Organic Dutchman Holdings Ltd. (TSX: TGOD; OTCQX: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (TSX: TGOD).

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC:TGODF) was highlighted today in an article focused on how Canada is on the cusp of legalizing recreational marijuana through Bill C-45, best known as the Cannabis Act, which is highly anticipated as being signed into in the near future.

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at

The Green Organic Dutchman (TSX: TGOD), closed the day's trading session at $7.10, up 4.41%, 245,731 volume with 625 trades. The average volume for the last 60 days is 171,020 and the stock's 52-week low/high is $2.784/$7.565.

Recent News


Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF)

The QualityStocks Daily Newsletter would like to spotlight Sunniva, Inc. (SNNVF).

Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF) ("Sunniva" or the "Company"), a North American provider of cannabis products and services, is pleased to announce that its wholly-owned subsidiary, Sunniva Medical Inc. ("SMI"), has closed its previously announced purchase of the 126-acre industrial zoned property in Okanagan Falls, BC, the site of the Sunniva Canada Campus (the "Campus").

Sunniva, Inc. (CSE: SNN) (OTCQX: SNNVF) is a vertically integrated medical cannabis company operating in the world’s two largest cannabis markets – Canada and California – committed to delivering safe, consistent, high-quality products and services. Sunniva operates through its wholly owned subsidiaries: Sunniva Medical Inc., CP Logistics, LLC, Natural Health Service Ltd., and Full-Scale Distributors, LLC. Sunniva’s vision is to become the lowest cost, highest quality cannabis producer in the markets it serves by building large scale purpose-built cGMP-compliant greenhouses, offering best quality assurance with cannabis products free from pesticides, providing better patient and doctor access to cannabis education, and sourcing better therapeutic delivery devices.

The company is establishing sophisticated distribution channels, including Sunniva’s ownership of Natural Health Services cannabis clinics in Canada with over 95,000 active patients, to purchase the significant quantities of high quality Sunniva-branded and Sunniva private-labeled cannabis products.

Sunniva is an ancient English name which means, “Gift of the Sun.” Sunniva’s team of horticulturists, scientists and engineers is helping to set best practices for the industry, believing that sun-grown, solar-powered cultivation is the most sustainable and cost-effective way to grow high-quality, premium cannabis.

The Sunniva Family includes:

CP Logistics, LLC

Through its subsidiary, CP Logistics LLC, Sunniva is developing Sunniva Campus, a state-of-the-art, purpose-built greenhouse facility in Cathedral City, California. This modern purpose-built, agri-technology greenhouse will adhere to the Current Good Manufacturing Practice (cGMP) regulations that assure proper design, monitoring and control of manufacturing processes and facilities.

Phase 1 of the project includes a fully funded 325,000 square foot greenhouse capable of producing 60,000 kg per year of dry cannabis at capacity with operations commencing Q3 2018. Approximately 30 percent of initial total production will be converted into oils and extracts. Phase 2 is expected to increase the greenhouse by 165,000 square feet and grow production by about 40,000 kg per year.

These uniquely sealed greenhouses are designed to deploy custom, automation assembly line cultivation processes at a large scale. Energy consumption will be reduced while utilizing the energy of the sun and microclimatic controls to provide precise growing conditions. The greenhouse will recirculate air for more efficient climate control, and the company’s Integrated Pest Management System is designed to ensure every plant grown is certified clean and free of all contaminants and pesticides.

Sunniva Medical Inc.

Sunniva Medical Inc. is designing and preparing to break ground on the Sunniva Canada Campus encompassing 700,000 square feet of purpose-built cGMP greenhouse facilities in the Okanagan Valley, British Columbia. The total campus is expected to produce 100,000 kg of premium medical cannabis a year plus additional trim used for extraction. This facility will produce pesticide-free products and will convert trim to extracted products such as cannabis oil that can be used for drug delivery formats such as capsules, dissolvable strips, vaporization cartridges, tinctures and creams.

Sunniva and Canopy Growth Corporation (“Canopy Growth”) recently announced a large take or pay supply agreement. Under the terms of the agreement, Canopy Growth will purchase up to 45,000 kilograms of dried cannabis annually commencing Q1 2019, which includes the distribution of Sunniva branded products. Sunniva Medical is a late-stage applicant under Canada’s ACMPR and is in the final review stage of the process.

Natural Health Services Ltd.

Natural Health Services (“NHS”) owns and operates a network of eight medical clinics in Canada specializing in medical cannabis under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”). NHS connects licensed producers to their 21 physicians and patients with its proprietary SPARK software which utilizes a software-as-a-service revenue model. To date, there are 27 integrated licensed producers utilizing the SPARK software.

In-house physicians specializing in the endocannabinoid system provide expert consultation, education and recommendations for targeted phytoceutical remedies and wellness plans to improve the quality of life for all patients. NHS enjoys a long-term relationship with patients due to the quality of its physician-patient experience. A rapidly expanding NHS cannabis clinic network serves 94,000 active patients in Canada. NHS has also initiated a pilot program with a national pharmacy chain to aggregate more patients.

Full-Scale Distributors, LLC

Full-Scale Distributors, LLC is an industry leading provider of custom, private-label vaporizers through its brand, Vapor Connoisseur. The company currently serves the needs of over 80 top brands in the North American marketplace. Vapor Connoisseur is recognized for its high quality and innovative therapeutic delivery devices. Products are tailored to client needs, ensuring both safety and reliability.

Sunniva’s highly experienced management team is building partnerships with leading scientists, universities and clinical trial groups to deliver proprietary cannabis formulations to a broad spectrum of health ailments and conditions. These global partners require cGMP-certified facilities for the processing and manufacturing of cannabis products. Sunniva is committed to providing safe, pesticide-free, high quality, reproducible cannabis medicines.

Leading Sunniva is co-founder, chairman and CEO Dr. Anthony (Tony) Holler. He is the former CEO and founder of ID Biomedical, which was acquired in 2005 for $1.7 billion by GlaxoSmithKline. He is also the former chairman of Corriente Resources Inc., which was sold for approximately $700 million to CRCC-Tongguan Investment Co. Holler is currently chairman of CRH Medical Corporation, a public company trading on the TSX and NYSE. His expertise includes strategic planning, mergers and acquisitions and financing with a singular focus on increasing shareholder value.

Holler is joined by co-founder Leith Pedersen, who serves as president of Sunniva. Pedersen is the former owner and CEO of Vida Wealth Management Bahamas and was a former investment advisor at Canaccord Wealth Management. He is a former partner and director at JF Mackie and Company, an independent brokerage firm in Calgary, Alberta, that managed capital in excess of $2 billion for high net worth clients. Pedersen’s expertise is in corporate strategy, financing and mergers and acquisitions.

Sunniva, Inc. (SNNVF), closed the day's trading session at $6.12, up 0.16%, on 22,363 volume with 43 trades. The average volume for the last 60 days is 36,018 and the stock's 52-week low/high is $5.86/$16.00.

Recent News


Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy Inc. (TSXV: PQE) (OTC: PQEFF) (FSE: A2DYWC) ("Petroteq" or the "Company"), a company focused on the development and implementation of proprietary technologies for the energy industry, announced today that it will be presenting at The MicroCap Conference being held on June 21, 2018 at the Sheraton Centre Hotel, Toronto.

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil and gas exploration and production on mineral leases it owns in Texas with Accord GR Energy Inc. and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ, the Company’s collaboration formed with First Bitcoin Capital Corp. (OTC: BITCF). PetroBLOQ’s novel blockchain-based oil and gas supply chain management platform is currently being co-developed by the two companies.

PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy CEO Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry. “API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 3,000-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Liquid Extraction System.

The company’s Texas location includes an ownership interest (46%) in 7,000 acres under mineral leases with Accord, a Houston-based oil and gas exploration company that focuses on the development and recovery of heavy oil reserves and deposits. Two enhanced, licensed oil recovery technologies designed to increase oil recovery from more than 80 shallow oil wells on the property are expected to substantially improve the recovery rates of heavy oil deposits in this area. In both the Utah oil sands and traditional oil patch Texas project, the Company, its subsidiaries and Accord are using proprietary technologies, processes and methodologies to recover heavy oil, providing a distinct, strategic economic advantage for Petroteq Energy and its shareholders.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy Inc. (PQEFF), closed the day's trading session at $0.8233, off by 0.81%, on 121,462 volume with 103 trades. The average volume for the last 60 days is 113,698 and the stock's 52-week low/high is $0.2395/$1.8892.

Recent News


Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF)

The QualityStocks Daily Newsletter would like to spotlight Lithium Chile Inc. (LTMCF).

NetworkNewsAudio announces the Audio Press Release (APR) titled "Lithium Demand Driving New Procurement Strategies," featuring Lithium Chile Inc. (TSXV: LITH) (OTCQB: LTMCF). To hear the NetworkNewsAudio version, visit: To read the original editorial, visit:

Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF), headquartered in Canada, is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex. The company’s wholly owned premier properties include 66 square kilometers on the Salar de Atacama, Chile’s largest mineral salt flat which hosts the world’s highest concentration of lithium brine production and is currently the source of about 35 percent of the world’s lithium production. Lithium Chile also owns a significant copper/gold/silver property portfolio consisting of 28,184 hectares over six different properties.

Lithium Chile’s portfolio in the heart of Chile’s lithium-rich salars includes Salar de Coipasa, Salar de Helados, Salar de Atacama, Salar de Turi Salar de Ollague and Salar de Talar. Surface and near surface salt and brine sampling programs on all properties has been completed. To date, samples of high-grade, near-surface lithium brines at each of these projects are showing excellent chemistry of lithium to potassium and lithium to magnesium ratios. Good chemistry is important as it reduces your overall cost of production. Recent geophysical surveys including T.E.M have been completed on 5 of 6 priority targets and data collected to date has been extremely encouraging.

Lithium Chile has identified multiple high-priority brine target areas at its Atacama and Ollague lithium project areas. These areas display the same geophysical characteristics as the lithium-rich aquifers at Salar de Atacama, home to the world’s largest and highest-grade lithium brine producers. Spanning an area of 1,200 square miles, Salar de Atacama is the world’s third largest salt flat behind Salinas Grandes in Argentina and El Salar de Uyuni in neighboring Bolivia. Exploration drilling and resource definition drilling for these target areas are planned for 2018.

“We are delighted with the discovery of such impressive drill target areas at Atacama and Ollague. The results also follow the recent discovery of a 60km2 target area at another of our top Chilean projects – Helados – where we hope to drill in the second quarter of 2018,” stated President and CEO Steve Cochrane. “We have an aggressive multi-project drill program planned for this year, which includes all three of these exciting projects and we look forward to sharing drill results as they come through.”

Global demand for lithium-ion batteries is expected to surpass US$53 billion by 2024 as governments around the world aggressively seek to ban gas-powered vehicles and major automakers invest billions in new technology and electric vehicles powered by lithium-ion batteries. Chile’s mining-friendly jurisdiction offers Lithium Chile a clear, streamlined permitting process that significantly lowers the cost of lithium production to around $1,800/ton as compared to Australia’s $5,000/ton.

Lithium Chile is led by an experienced team with strong Chilean connections. Cochrane’s 36 years of investment industry experience have primarily been focused on the mining sector. During this time, he raised more than US$500 million for a variety of small cap public companies in various businesses and industry sectors including mining.

Terry Walker, P.Geol., vice president of exploration and chief geologist, is a highly experienced geologist. He has spent over 25 years in Chile’s mining industry and is well connected throughout the sector. Walker is co-founder of GeoServicios Piedra Dorada, an exploration and development services company focused on Latin America. He is a Qualified Person for the North American and Australian stock exchanges.

Lithium Chile is well funded and driven by a top-tier team with more than 100 years of combined experience in financing, mining exploration and development in the natural resources sector.

Lithium Chile Inc. (LTMCF), closed the day's trading session at $0.7446, off by 5.75%, on 65,400 volume with 78 trades. The average volume for the last 60 days is 19,722 and the stock's 52-week low/high is $0.5946/$0.9614.

Recent News


Net Element (NASDAQ: NETE)

The QualityStocks Daily Newsletter would like to spotlight Net Element (NETE).

Net Element, Inc. (NASDAQ: NETE) was highlighted today in an article detailing Blockchain’s strong year, with The Wall Street Journal having released its annual list of “Tech Companies to Watch,” where in 5 of the 25 companies listed were blockchain-related.

Net Element (NETE), is a global financial technology and value-added solutions group that supports electronic payments acceptance in an omni-channel environment spanning across point-of-sale, e-commerce, and mobile devices. Net Element operates a payments-as-a-service transactional model and value-added services platform for small to medium enterprises in the U.S. and selected emerging markets. Internationally, Net Element’s strategy is to leverage its omni-channel platform to deliver flexible offerings to emerging markets with diverse banking, regulatory and demographic conditions. Net Element was ranked as one of the fastest growing companies in North America on Deloitte’s 2017 Technology Fast 500 ™ and South Florida Business Journal’s 2016 fastest growing technology companies.

Net Element believes the future of global commerce is being revolutionized as consumers quickly migrate toward omni-channel shopping utilizing mobile devices, desktop, and online services. Net Element’s all-in-one payment solutions support and unify a whole range of applications through a single, robust platform, allowing global onboarding and support for multiple payment methods.

In a partnership with Bunker Capital, Net Element has also launched a new blockchain-focused business unit that will develop and deploy blockchain technology-based solutions. Net Element expects the new division to create a decentralized crypto-based ecosystem that will act as a framework for an unlimited number of value-added services, connecting merchants and consumers in a seamless, economically efficient transaction. This new business unit intends to also identify and invest in unique projects that decentralize and disrupt the payment processing industry by combining blockchain technology and real-world applications with talented development teams, strong fundamentals and addressable markets large in size.

“We believe that we’re at the dawn of a new evolution where additional digital payment methods are being introduced,” Net Element CEO Oleg Firer, says. “Introduction of our division focused on blockchain as part of the NASDAQ-listed entity will add transparency and compliance assurance to our investors as well as provide access to deploy value-added services to over 20 million electronic commerce clients that are currently part of Net Element’s growing network.”

Net Element clients are treated to customized solutions that provide the flexibility needed to keep up with customers. Among the services offered are mobile payment apps that accept payments anywhere, anytime; cloud-based solutions built to increase productivity and enhance revenue for clients and partners; marketing solutions that turn lookers into buyers; and business analytics that make it easy for clients to monitor business metrics, engage with customers and compare the competition. Its multi-channel platform combines e-commerce, offline, point-of-sale, comprehensive back office tools, mobile point-of-sale, credit scoring and customer interaction in one powerful platform-as-a-service technology.

Net Element owns and operates a global mobile payments and transactional processing provider, TOT Group, Inc., with the following subsidiaries:

  • Unified Payments – An award-winning, customized mobile billing and payments solution, recognized by Inc. Magazine as the No. 1 Fastest Growing Company in America in 2012.
  • Digital Provider – A leading provider of SMS messaging and mobile billing solutions.
  • Aptito – A next-generation, all-in-one, cloud-based restaurant management and point-of-sale payments platform using wireless technology.
  • Payonline – A fully integrated, processor agnostic electronic commerce platform.

Net Element is ranked No. 418 on Deloitte’s 2017 Technology Fast 500™ list of North America’s 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies. Net Element grew 190 percent. The company’s chief executive officer, Oleg Firer, credits the company’s progression to organic growth in its North America Transactions Segment, specifically the success of its Unified Payments brand, which focuses on value-added payment acceptance solutions for small to medium enterprises in the United States.

“The Deloitte 2017 North America Technology Fast 500 winners underscore the impact of technological innovation and world class customer service in driving growth, in a fiercely competitive environment,” said Sandra Shirai, vice chairman, Deloitte Consulting LLP and U.S. technology, media and telecommunications leader. “These companies are on the cutting edge, and are transforming the way we do business.”

Net Element’s suite of application performing interfaces (APIs) and connectors power commerce for businesses of all sizes through multi-channel platforms, all-in-one digital solutions, and end-to-end encryption of cardholder data utilizing tamper resistant hardware that ensures integrity and simplifies security.

Net Element’s corporate team is led by director and CEO Oleg Firer, who is responsible for the overall vision, strategy and execution of the company’s mission of powering global commerce. He is joined by CFO Jonathan New, CPA, and Steven Wolberg, who is the company’s chief legal officer and secretary. Each corporate officer brings a unique blend of leadership, vision, experience and creative energy to the company.

From mobile payments and value-added transactional innovations such as Digital Provider and Aptito to e-commerce and retail payment transaction processing brands like Payonline and United Payments, Net Element is transforming the online and mobile experience.

Net Element (NETE), closed the day's trading session at $8.08, off by 7.23%, on 203,165 volume with 896 trades. The average volume for the last 60 days is 446,509 and the stock's 52-week low/high is $2.556/$33.51.

Recent News


FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)

The QualityStocks Daily Newsletter would like to spotlight FinCanna Capital Corp. (FNNZF).

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) a royalty company for the U.S. licensed medical cannabis industry, is pleased to announce that following higher than anticipated demand the Company has increased the size of its previously announced non-brokered private placement financing from C$3 million to C$5 million. FinCanna will now issue up to 16,666,667 Units at a purchase price of C$0.30 per Unit. Also today, FNNZF announced it has engaged the corporate communications expertise of NetworkNewsWire ("NNW").

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.

Medical Cannabis Market

According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.

Royalty Model & Portfolio

FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.

FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.

CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.

The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.

Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.

FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.

The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.

FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.2431, off by 7.74%, on 92,222 volume with 31 trades. The average volume for the last 60 days is 32,757 and the stock's 52-week low/high is $0.10/$0.8736.

Recent News


Choom Holdings Inc. (CSE: CHOO) (OTCQB: CHOOF)

The QualityStocks Daily Newsletter would like to spotlight Choom Holdings Inc. (CHOOF).

Choom™ (CSE: CHOO; OTCQB: CHOOF) (the "Company" or "Choom"), an emerging fully-integrated cannabis company, is pleased to announce it has closed its previously announced non-brokered private placement (June 13, 2018). The Company issued 14,225,352 shares for total gross proceeds of $10.1 million. Aurora Cannabis is the cornerstone investor in the placement with a lead order of $7 million. All securities issued are subject to a four month hold period. Also today, the company was highlighted in an article detailing Blockchain’s strong year, with The Wall Street Journal having released its annual list of “Tech Companies to Watch,” where in 5 of the 25 companies listed were blockchain-related.

Choom Holdings Inc. (OTCQB: CHOOF) (CSE: CHOO) channels the laid-back spirit of Hawaii to the Okanagan region of British Columbia with a generous nod to the inspirational, yet unofficial, history of the 1970s “Choom Gang,” a group of buddies in Honolulu (including former President Barack Obama) who knew how to relax with “choom,” the local’s term for marijuana. Choom’s trademark slogans pivot off another unconventional phrase (“Say Hello to…”), bringing a heady dose of good times and good friends together as the company invites investors to “Say Hello to Choom™” as it lights up the adult recreational cannabis market in Canada.

Choom™ has been an ACMPR (Access to Cannabis for Medical Purposes Regulations) applicant since November 2013 in Vernon, B.C. The company’s first application has received security clearance and is now in the detailed review stage. They also recently announced their second late-stage ACMPR application, which is in its confirmation of readiness stage. Cannabis Compliance Inc. has been retained to help expedite Choom’s initial license applications to ensure the company’s readiness for legalization of recreational marijuana in Canada mid-summer 2018.

True to the company’s character, Choom™ is retrofitting two large facilities – No. 1 in Vernon, B.C., and No. 2 on Vancouver Island – to house its cannabis growing facilities. Phase 1 of the Vernon property will provide Choom™ with 6,800 square feet of growing space, capable of producing 660 kg/year of cannabis at an estimated revenue of $6.6 million, excluding oils. The company expects this facility to be completed by July 2018, the same month that Canada is expected to formally legalize recreational marijuana for adult use. A potential Phase 2, to be completed by the end of 2018, would add another 6,800 square feet for a total of 1,500 kg/year capacity, which would nearly double No. 1’s revenue. A Level 9 vault is also planned with a storage capacity of 15,000 kg. While the No. 2 facility on Vancouver Island is smaller – 4,500 square feet – its retrofit is also slated to be completed by July 2018. Plans include doubling this space as well, which would add about $9 million in annual revenue, excluding cannabis oils.

Choom™ announced its retail dispensary strategy with the intention of establishing market leadership in reaching the Canadian cannabis consumer. The partner program is already in the retail space design stage as the company seeks to build a chain of branded retail cannabis dispensaries in jurisdictions in Canada where recreational cannabis is legal. Choom™ Stores will have a cool, modern layout and design created to emit an authentic “Aloha” vibe. Choom™ is all about producing high-grade cultivars and curating them for a bigger audience.

A savvy, experienced management team includes Chris Bogart, president and CEO; John Oh, R.P.I.C., Operations Manager; Robert Bayrack, Master Grower, S.P.I.C.; and Adrian Robinson, Strategic Advisor. Bogart has over two decades of international experience in capital markets and was a co-founder of InMed Pharmaceuticals and Magnum Uranium. He has structured complex equity financing transactions in the U.S., Europe and Canada. Bogart is joined on the Board of Directors by Kevin Pull, Stephen Tong and John Oh.

While the medical marijuana industry is expected to double by 2021 to 500,000 registered users, the true highlight of the recreational cannabis represents the key cultural shift set to launch in Canada. With an estimated $4.9B to $8.7B retail market coming, now is the right time for a Recreation Brand like Choom™ to be involved in this growing industry. Establishing and maintaining Choom™ premium brand loyalty is a key factor in the company’s growth strategy. Get ready to “Say Hello” to opportunity, good times and good friends with Choom™.

Choom Holdings Inc. (CHOOF), closed the day's trading session at $0.941, off by 9.52%, on 2,332,605 volume with 1,924 trades. The average volume for the last 60 days is 388,379 and the stock's 52-week low/high is $0.18/$1.049.

Recent News


Virtual Crypto Technologies Inc. (OTCQB: VRCP)

The QualityStocks Daily Newsletter would like to spotlight Virtual Crypto Technologies Inc. (VRCP).

CryptoNewsAudio announces the Audio Press Release (APR) titled "Crypto Companies Prepare for Inevitable Regulation that Could Be the Sector's Biggest Boon Yet," featuring Virtual Crypto Technologies Inc. (OTCQB: VRCP). To hear the CryptoNewsAudio version, visit: To read the original editorial, visit:

Virtual Crypto Technologies Inc. (OTCQB: VRCP) is a developer of software and hardware for the purchase and sale of cryptocurrencies through ATMs, tablets, PCs and mobile devices. The company’s proprietary algorithmic technology trading platform, called NetoBit Trader, can instantaneously confirm the purchase or sale of Bitcoin, a process that typically can take between 10 minutes to 24 hours. All trades and exchanges are insured up to $3,000 per trade. The global cryptocurrency ATM market is predicted to surpass $285 million by 2025, yet, at present, only 30 percent of these machines allow two-way trades.

With NetoBit Trader, cryptocurrency holders enjoy immediate confirmation of Bitcoin and its crypto equivalents at the best crypto exchange rate at the point of transaction – providing a major breakthrough in the quest to bring cryptocurrencies to the mass market. Virtual Crypto’s cryptocurrency ATM, embedded with currency exchange transaction validation (CETV) in its hardware and software, accepts and dispenses cash and cryptocurrency in seconds.

Virtual Crypto’s NetoBit Trader and mobile retail point-of-sale platform incorporates advanced technologies tailored to the needs of primary market players, users, investors, and business owners. Virtual Crypto’s platform bridges the three main functions of the cryptocurrency sector – exchanges, wallets and payments – to the world of fiat exchanges, granting access to immediate cash exchanges between consumers and businesses worldwide.

NetoBit Trader’s over-the-counter, two-way transaction solution is available through one app, providing online cryptocurrency transactions at ecommerce and gaming portals. The app provides real-time cryptocurrency validation and exchange, easy buying and selling of Bitcoin with cash, enables traders to buy and trade crypto, and gamers to transfer cryptocurrency into cash after play. Crypto users can withdraw funds from their crypto accounts through a NetoBit cryptocurrency ATM or software-enabled tablet, and consumers can purchase retail with crypto from businesses that offer and use the NetoBit software.

The company’s newly redesigned corporate website,, delivers a simple, clean design with enhanced functionality, features and navigation. Virtual Crypto’s new corporate website includes:

  • Downloadable NetoBit Trader app link and contact forms for more information
  • MarketWatch provides real-time tracking of the Bitcoin market, with other currencies to follow
  • Improved security utilizing https certificates to protect personal information and site integrity
  • Media room with downloadable product brochures, corporate presentations and other relevant content
  • Investor’s page provides transparency to investors with direct access to Virtual Crypto’s progress through press releases, SEC filings, senior management team bios, and stock performance charts
  • Social Media integration with buttons for LinkedIn, Twitter and Facebook jump to Virtual Crypto’s social media profiles, providing real-time updates from the online community

“Our primary objective is to make cryptocurrencies accessible to everyone, and that was the motivation for our redesign,” said Alon Dayan, Chief Executive Officer of Virtual Crypto. “The updated content provides real value for our customers, shareholders and employees, showcasing our products and services, in an intuitive, easy to navigate way.”

Virtual Crypto’s strategic vision of “Cryptocurrency Made Easy” allows crypto traders and users to overcome the complex hurdles currently hampering the cryptocurrency sphere.

Virtual Crypto Technologies Inc. (VRCP), closed the day's trading session at $0.1475, up 10.61%, on 54,589 volume with 21 trades. The average volume for the last 60 days is 38,455 and the stock's 52-week low/high is $0.0125/$0.38.

Recent News


BLOCKStrain Technology Corp. (TSXV: DNAX)

The QualityStocks Daily Newsletter would like to spotlight BLOCKStrain Technology Corp. (DNAX).

At the request of IIROC, BLOCKStrain Technology Corp. (TSX-V: DNAX) wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity. Also today, CannabisNewsWire released a report on the company detailing how BLOCKStrain’s blockchain platform is perfectly positioned for the tide of cannabis legalization washing over America when it comes to key aspects of the market, like determining how to best ensure that marijuana in the marketplace is safe to consume, or helping breeders and growers to stop their strains from being ‘faked.’

BLOCKStrain Technology Corp. (TSX.V: DNAX), a full-service software company headquartered in Vancouver, BC, Canada, has developed the first integrated blockchain platform that registers and tracks cannabis intellectual property (“IP”) from genome to sale. It is proprietary, immutable and cryptographically secure, thereby establishing a single source of truth for cannabis strains and their ownership.

With Canada set to legalize marijuana use for recreational purposes, and other jurisdictions following suit around the world, new challenges will emerge regarding the ability to provide a safe and legal inventory of a product that up until now was largely only available on the black market. Cannabis will be heavily tested and regulated by numerous regulatory bodies in Canada. The cannabis industry faces unique challenges that BLOCKStrain specifically helps it address, including:

  • Mandatory Testing: Through BLOCKStrain’s platform and lab-testing partners, the process is more efficient and streamlined, cutting the administrative burden in half and getting products to market faster;
  • DNA Based Product Validation: The underlying blockchain technology creates a genetic fingerprint that identifies and validates the product electronically so any participant on the platform, including consumers, can view and track what’s happening with that product from genome to sale;
  • Intellectual Property: Third, and perhaps most importantly, the BLOCKStrain platform protects the intellectual property of growers and breeders. This is important for the industry’s growth as products evolve and develop. If a craft grower, for example, creates a popular strain with unique characteristics, it will be able to protect its intellectual property by simply registering the strain’s genome with BLOCKStrain and locking that data into the blockchain. It will reside there forever and will be readily accessible in the event of future disputes, bringing a level of trust to the industry and ensuring licensing fees are paid to all players in the market.


BLOCKStrain’s genetics verification process is authentic and incredibly effective. User groups register by creating an account with BLOCKStrain, which starts the process. Organizations and independent growers submit seeds, flower and post-extraction product for testing to a registered and approved testing facility, which then submits test results to BLOCKStrain. Pre-existing data of genetic cannabis strains can also be submitted via BLOCKStrain verification administrators, with those results being added to the user group’s blockchain account. Submissions are entered into BLOCKStrain, and the transaction is completed and recorded.

Each time an item is tested and verified by the network, a Registration Affidavit is auto-generated and given a unique “BLOCKStrain Address” along with a traceable QR Code. Producers, patients and consumers are able to not only verify the test but can also rate the product, write reviews and share opinions. This detail is stored within BLOCKStrain and, just like the test results, cannot be tampered with or modified. Verification and certification are earned by all parties for their participation.


BLOCKStrain demystifies the seed-to-sale process for all relevant stakeholders including producers, distributors, shippers, government agencies and consumers by creating a repository of cannabis genomes on an immutable, shared ledger. Thousands of cannabis strains exist and cultivators are breeding new strains all the time. The proliferation of cannabis strains can prove problematic for consumers since there are more than 500 known chemical compounds in a single plant. Furthermore, since several dozens of these compounds have been identified as pharmacologically active, it becomes more and more difficult for consumers to know what they are purchasing.

It is for this reason that being able to quantify the genetics, potency and equivalencies among cannabis products is crucial to the future of legalized cannabis. The difference is not so much in the name or brand attached to the cannabis, but the DNA of the plant itself. BLOCKStrain ensures product integrity, safety, regulatory compliance, product licensing and authenticity – all vital elements for the emerging cannabis industry.  This technology also bolsters the process of meeting government regulatory standards by providing real-time visibility of industry operations to agencies assigned to enforce and regulate cannabis activity.


BLOCKStrain allows for the defense of intellectual property rights for the grower with an authentic, verifiable chain of evidence embedded in the blockchain itself. Proof of ownership for a specific strain of cannabis is paramount in a multibillion dollar industry. Real life ownership disputes have already begun in the industry with legal battles underway. Unfortunately, the framework for resolving these disputes has yet to be defined and they are not likely to be resolved anytime soon.

Consumers and regulators alike want to know whether a cannabis product grown and sold at a local dispensary is safe and meets quality control standards. BLOCKStrain enhances trust of origin from genome-to-sale as cannabis flows through the supply chain, verifying critical steps in the process such as who is growing the plant, which seed is planted and where did it come from, whether pesticides were used, how much was grown, which tests are used to establish quality and potency, where the product is transported and how, and whether possession limits are meeting regulatory standards.

In summary, BLOCKStrain has developed the most comprehensive, secure and community-driven cannabis genetics archival platform for cannabis breeders and growers, large and small, to protect and release their varieties into the public domain, all while compensating and rewarding them for their contributions.

BLOCKStrain Technology Corp. (DNAX), closed the day's trading session at $0.50, off by 16.67%, on 871,590 volume. The stock's 52-week low/high is $0.10/$1.20.

Recent News


The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.